Policy | August 09, 2021
China NMPA approves phase II clinical trial of ASC40
Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
Phase II trial will evaluate the safety and efficacy of ASC40 in patients with moderate to severe acne
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
All India Institute of Ayurveda hosts ministers and showcase their achievements
The transaction is expected to close in the Q4FY22
Ibuprofen and Famotidine Tablets is an AB-rated generic therapeutic equivalent version of Horizon Medicines LLC’s Duexis Tablets, 800 mg/26.6 mg
The proposed acquisition will further bolster Strides US presence through acquisition of a multi dosage facility in the US.
CDSCO to fast-track trials and approval for COVID19 vaccine
AstraZeneca, Sinopharm and Moderna were part of the study
The data should be submitted by August 12th 2021
Subscribe To Our Newsletter & Stay Updated
